Purpose: Considerable progress has been made in the assessment and management of nonsmall cell lung cancer (NSCLC) patients based on mutation status in the epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene (KRAS). At the same time, NSCLC management through KRAS and EGFR mutation profiling faces challenges. In the present work, we aimed to evaluate a comprehensive radiomics framework that enabled prediction of EGFR and KRAS mutation status in NSCLC patients based on radiomic features from low-dose computed tomography (CT), contrast-enhanced diagnostic quality CT (CTD), and positron emission tomography (PET) imaging modalities and use of machine learning algorithms. Methods: Our study involved NSCLC patients including 150 PET, low-dose CT, and CTD images. Radiomic features from original and preprocessed (including 64 bin discretizing, Laplacian-of-Gaussian (LOG), and Wavelet) images were extracted. Conventional clinically Electronic supplementary material The online version of this article (https:// used standard uptake value (SUV) parameters and metabolic tumor volume (MTV) were also obtained from PET images. Highly correlated features were pre-eliminated, and false discovery rate (FDR) correction was performed with the resulting q-values reported for univariate analysis. Six feature selection methods and 12 classifiers were then used for multivariate prediction of gene mutation status (provided by polymerase chain reaction (PCR)) in patients. We performed 10-fold cross-validation for model tuning to improve robustness, and our developed models were assessed on an independent validation set with 68 patients (common in all three imaging modalities). The average area under the receiver operator characteristic curve (AUC) was utilized for performance evaluation. Results: The best predictive power for conventional PET parameters was achieved by SUV peak (AUC 0.69, p value = 0.0002) and MTV (AUC 0.55, p value = 0.0011) for EGFR and KRAS, respectively. Univariate analysis of extracted radiomics features improved AUC performance to 0.75 (q-value 0.003, Short-Run Emphasis feature of GLRLM from LOG preprocessed image of PET with sigma value 1.5) and 0.71 (q-value 0.00005, Large Dependence Low Gray-Level Emphasis feature of GLDM in LOG preprocessed image of CTD with sigma value 5) for EGFR and KRAS, respectively. Furthermore, multivariate machine learning-based AUC performances were significantly improved to 0.82 for EGFR (LOG preprocessed image of PET with sigma 3 with variance threshold (VT) feature selector and stochastic gradient descent (SGD) classifier (q-value = 4.86E-05) and 0.83 for KRAS (LOG preprocessed image of CT with sigma 3.5 with select model (SM) feature selector and SGD classifier (q-value = 2.81E−09). Conclusion: Our work demonstrated that non-invasive and reliable radiomics analysis can be successfully used to predict EGFR and KRAS mutation status in NSCLC patients. We demonstrated that radiomic features extracted from different image-feature sets could be used for EGFR and KRAS mutation status prediction in NSCLC patients and showed improved predictive power relative to conventional image-derived metrics.
Introduction
Considerable progress has been made recently in the assessment and management of non-small-cell lung cancer (NSCLC) based on mutation status in the epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene (KRAS) genes [1, 2] . Ongoing studies on molecular cancer profiling have revealed that EGFR and KRAS are involved in the occurrence, development, invasion, and metastasis of NSCLC [3] . Moreover, studies have indicated that mutations in KRAS and EGFR are considered as first lines for clinical decision-making in NSCLC treatment and outcome improvement [4] . Furthermore, recent studies have identified that NSCLC patients with mutant KRAS tumors fail to benefit from adjuvant chemotherapy, and their disease does not respond to EGFR inhibitors [5] . In addition, it was reported that outcomes and patterns of failure in genotypic subgroups of NSCLC patients, based on mutations in EGFR or KRAS, can inform the design of future trials integrating targeted therapies [6] .
Although KRAS and EGFR mutation profiling is critical in NSCLC management, some studies have raised issues with this approach [7] . First, such mutation status captures only a small degree of tumor heterogeneity and does not provide a complete picture for the assessment of tumor characteristics. Secondly, this method depicts low repeatability and is not feasible for all cases [8] . Furthermore, the method suffers from invasiveness and patients discomfort [9] .
As a recently developed paradigm of advanced medical image quantification, radiomics has garnered significant interest given its cost-effectiveness and reliability to characterize tumor heterogeneity and has enabled improved assessment of therapy response and prediction of molecular pathways [10] [11] [12] . Accumulating evidence has identified several radiomic features extracted from computed tomography (CT), magnetic resonance (MR), or positron emission tomography (PET) images as highly correlated with genomic parameters in several cancers [8, 13, 14] . For NSCLC patients, radiomics studies have shown that several CT image features can predict mutation status in EGFR and KRAS [8] . For example, features such as size, edge, lucency, and homogeneity extracted from CT images could identify EGFR mutation status [15] . Also, some diffusion-weighted (DW) MR image-intensity histogram features, including mean, skewness, and 10th and 90th percentiles, have been shown to predict EGFR mutation in lung adenocarcinoma [16] . On the other hand, Velazquez et al. developed radiomics models based on CT image features and clinical parameters to distinguish between EGFR − and EGFR + and KRAS + and KRAS − [17] . Liu et al. also evaluated the ability of CT image features to predict EGFR mutation status in 298 surgically Shiri I. et al.: Imaging-Genomics Analysis for EGFR and KRAS Prediction resected peripheral lung adenocarcinomas in an Asian cohort of patients and built a high-performance predictive model by using multiple logistic regression algorithms [15] . Zhang et al. also developed a radiogenomic model based on CT image features to predict EGFR and KRAS mutations in lung adenocarcinoma patients [18] . Wang et al. [19] and Zhao et al. [20] recently reported on a deep learning and radiomics study on EGFR prediction using CT images. Their radiomics study includes one feature selector (recursive feature elimination, ICC reproducibility test) and classifier (random forest, Logistic regression). They concluded that deep learning can be a non-invasive tool for the prediction of EGFR mutation status. Li et al. [21] investigated EGFR mutation status using PET SUV biomarkers as well as radiomics features. They reported the feasibility of quantitative measurement of tumor phenotype using radiomics. More recently, Pinheiro et al. [22] presented a radiomic study using semantic and radiomic features on EGFR and KRAS prediction using only CT image features. They concluded that lung semantic features in conjunction with tumor-specific semantic features can improve the prediction power of gene mutation status while the radiomic features did not provide good prediction power.
Incorporating radiomics for a prediction study requires a multi-step process that involves reliable statistical analyses, such as feature selection and classification, to reduce overfitting and to build robust predictive or prognostic models [23] . A number of machine learning (ML) algorithms can provide robust means to identify a subset of features to combine into a multi-parametric model [24] . Although several ML algorithms, alone or in combination, have been used in radiomics analysis for feature selection and classification, there is no "one fits all" approach as performance of various ML workflows has been shown to depend on application and/or type of data [25] [26] [27] [28] . Previous studies have tested cross-combination of different ML approaches and have suggested distinct ML algorithms that depict high performance for feature selection and classification [24, 25] .
In the present study, we aimed to evaluate a comprehensive multimodal (diagnostic CT, low-dose CT, and PET modality) radiomics, univariate analysis, and machine learning framework to predict EGFR and KRAS mutation status in NSCLC patients.
Materials and Methods

Radiomics Analysis
Our radiomics analysis included seven steps as shown in Fig. 1 and elaborated next.
Data Collection
This study was conducted on 211 NSCLC patients with available imaging and genomic data.
Imaging studies for all patients were obtained from The Cancer Imaging Archive (TCIA) [29] [30] [31] [32] and included contrast-enhanced diagnostic quality CT (CTD) and PET/ CT (i.e., low-dose CT (CT) as used for PET attenuation correction and the PET image). The clinical characteristics of all patients are presented in Table 1 while the inclusion and exclusion criteria are presented in Fig. 2 . Detailed information about image acquisition and generation were presented in previous works [29] [30] [31] [32] .
Imaging
All images were acquired with two vendors of imaging systems, including GE Healthcare and Siemens Healthcare. For CTD, 73 % of data were acquired on a GE Discovery CT750HD and 27 % on a Siemens. Slice thicknesses for CTD were 0.625-3 mm (median 1.5 mm) and an x-ray tube current of 124-699 mA (mean 220 mA) at 80-140 kVp (mean 120 kVp), and spiral pitch factor of 0.9-1. A GE Discovery D690 PET/CT and a GE Discovery PET/CT scanner were used for PET/CT scanning. 18 F-FDG injected activity and uptake time were 138.90-572.25 MBq (mean 309.26 MBq) and 23.08-128.90 min (mean 66.58 min), respectively. Each bed position acquisition time was 1-5min, where iterative Ordered Subset Expectation Maximization (OSEM) algorithm was used for PET image reconstruction. Slice thicknesses for low-dose CT were set to 3-5 mm, mA range 36-400, kVp 120-140, and spiral pitch factor 0.9-1. Due to certain problems, including image noise, artifacts, absence of images for some sequences, and image mis-segmentation, some patients were excluded. All in all, 186 PET and 175 lowdose CT and CTD images were segmented.
Genomics
Tumor samples were excised and cut by a surgeon with slice thickness of 3-5 mm and were frozen for 30 min. For single nucleotide mutation detection, SNaPshot technology based on dideoxy single-base extension of oligonucleotide primers was performed after multiplex polymerase chain reaction (PCR) [33] . To detect EGFR mutations, Exons including 18, 19, 20, and 21 were assessed. In addition, Exon 2 positions 12 and 13 were examined with amino acid substitution for missense KRAS mutations.
Image Preprocessing Prior to feature extraction, all images were preprocessed with interpolation (sitkBSpline algorithm, B-spline of order 3 interpolation) to isotropic voxel spacing to be rotationally invariant, for feature extraction to allow comparison between image data from different samples and scanner and center. Re-sampling to 1 × 1 × 1, 1 × 1 × 1, and 3 × 3 × 3 mm 3 was performed for CTD, CT, and PET images respectively. Laplacian of Gaussian (LOG), wavelet decomposition (WAV), and Shiri I. et al.: Imaging-Genomics Analysis for EGFR and KRAS Prediction discretized into 64 bins (BIN64) preprocessing were performed to generate different set of features. For LOG filter, different sigma values were used to extract fine, medium, and coarse features; specifically, they ranged from 0.5 to 5 with 0.5 steps [34] . Wavelet filtering yields eight decompositions per level (all possible combinations of applying either a high-or a low-pass filter in each of the three dimensions, including HHH, HHL, HLH, HLL, Image Segmentation All PET image segmentations were performed using OSIRIX® [35] . Lesions were delineated manually on PET images. CT images were segmented via automatic region growing using 3D-Slicer [36] and were edited and verified by an experienced radiologist. In total, we provide the analysis of 150 PET, low-dose CT, and CTD segmentations.
Feature Extraction In the next step, several features from different feature classes were extracted. The classes include first-order statistics (19 FOS features), shape-based (16 Shape features), gray-level co-occurrence matrix (GLCM 23 features), gray-level run length matrix (16 GLRLM features), gray-level size zone matrix (16 GLSZM features), neighboring gray tone difference matrix (5 NGTDM features), and graylevel dependence matrix (14 GLDM features). Image feature extraction was performed using the open-source python library PyRadiomics [37] . Radiomic features calculated by this package are in compliance with feature definitions described by the image biomarker standardization initiative (IBSI) that ensures the harmonization and reproducibility of calculated radiomic features, and thus facilitates the reproducibility of this study [37, 38] . More details about the feature classes are provided in Table 2 .
In addition to the radiomic features, we also extracted conventional clinical PET biomarkers including metabolic tumor volume (MTV) and standard uptake values (SUV max , SUV peak ), including normalization to lean body mass (SUL max, SUL peak ). Feature Selection We implemented six different feature selection methods in our framework and compared their performances (Table 3 ). These feature selection techniques, including filter-based method (select K Best (SKB), variance threshold (VT), and select percentile (SP)), embedded-based method (select from Model (SM)), and combine methods (variance threshold and select from model (VT-SM) and variance threshold and select K best (VT-KB)).
Classification (Multivariate)
We implemented and compared 12 classifiers (Table 4 , details of each classifier are provided in supplemental Table 1 ). Different methods of classification, including generalized linear models (logistic regression and stochastic gradient descent (SGD)), naive Bayes models (naive Bayes and Gaussian naive Bayes), nearest neighbor's model (k-nearest neighbors), decision trees model (C5.0), quadratic discriminant analysis model (QDA), support vector machines (SVC), supervised neural network models (multilayer perceptron), and ensemble learning methods (adaptive boost, bagging and random forest) were used in this study.
Analysis
Univariate Analysis
For univariate analysis, each feature value was normalized to obtain Z-scores followed by student t test statistical analysis for comparison. A p value of G 0.05 was used as a criterion for statistically significant differences. Spearman correlation between features was performed to eliminate highly correlated features while the false discovery rate (FDR) correction was assessed and reported along with the q-value (FDR adjusted p value). Statistical analysis was performed using R 3.5.1 software (using "pROC" and "stats" packages). We also studied the prediction performance of conventional clinical image-derived PET metrics (SUV max , SUV peak , SUL max, SUL peak , and MTV).
Multivariate Analysis
All our analyses, including feature selection and classification, were performed using an in-house developed python framework in open-source python library Scikit-Learn [39] . Cross-validation (CV) was applied to models, and tuning of models was performed on testing set of 10-fold CV (sample is randomly partitioned into 10 equal size subsamples. Of the 10 subsamples, a single subsample is retained as the test data, while the remaining nine subsamples are used as training data, repeated for 10 times). This process was performed 20 times to get the highest stable results. Furthermore, model evaluation was performed on independent validation sets (68 patients). The predictive power of all features was investigated using the area under the receiver operator characteristic (ROC) curve (AUC). A heatmap was generated to compare the different models. Mean ± standard deviation (SD) of AUC of all classifier and feature selection algorithms were calculated and depicted. The cross-combination of feature selection and classification methods were depicted as a heatmap (mean AUC value in cross-validation).
NSCLC patients with PET/CT, CTD , EGFR and
Results
Univariate Analysis
EGFR The results of EGFR mutation status prediction after elimination of high correlated features in each image 
Shape Features of EGFR and KRAS
Details of EGFR and KRAS mutation status prediction using shape features, including AUC, p value, and q-value, are presented in supplementary figures 7-9, respectively. The Surface Volume Ratio feature from PET images (AUC 0.60, q-value 0.28) and Flatness from CT images (AUC: 0.67, qvalue:0.11) had highest prediction power in EGFR and KRAS, respectively; however, the differences were not statistically significant.
Conventional PET Metrics
Our univariate analysis on conventional PET metrics for EGFR mutation status prediction showed that SUV peak with AUC = 0.69 (p value = 0.0002) had the highest performance.
The results for SUL peak , SUV max , SUL max , and MTV were 0.60 (p value = 0.0003), 0.59 (p value G 0.0001), 0.55 (p value G 0.0001), and 0.56 (p value = 0.0004), respectively. Our results involving conventional features for KRAS mutation status prediction were all poor: MTV (AUC 0.55, p value = 0.0011), SUV max (AUC 0.52, p value G 0.0001), SUL max (AUC 0.53, p value G 0.0001), SUV peak (AUC 0.52, p value = 0.0013), and SUL peak (AUC 0.51, p value = 0.0008).
Multivariate Machine Learning Radiomic Models
EGFR Figure 3 shows a heatmap of EGFR mutation status prediction results with different combinations of feature Our results for EGFR mutation status prediction based on feature selection methods and image sets are depicted in supplemental Tables 4 and 5 (mean ± SD and Min-Max). It can be deduced from these results that selection performance ranges from 0.51 to 0.82, and the combination of VT_SM feature selection with PET_W_LHH image sets had the highest performance (AUC 0.73 ± 0.074 and 0.58-0.81), followed by SM feature selection with PET_W_LHH image set (AUC 0.72 ± 0.079 and 0.5-0.8), VT feature selection with PET_W_LHH image set (AUC: 0.71 ± 0.065 and 0.6-0.79), and SKB feature selection with PET_W_LHH image set (AUC 0.7 ± 0.06 and 0.6-0.78). Figures 4 and 5a indicate the box plot of EGFR mutation status prediction based on feature selection methods.
Supplemental Tables 6 and 7 (mean ± SD and Min-Max) show the results regarding EGFR mutation status prediction based on classifiers and image sets. According to these results, classifier performance has a range from 0.50 to 0.82 and combination of RF classifier with PET_W_LHH image set had the highest performance (AUC: 0.76 ± 0.024 and 0.73-0.79), followed by BNB classifier with PET image set which discretized into 64 Bin (PET_BIN64) (AUC 0.75 ± 0.0096 and 0.74-0.76) and SVM classifier with PET_W_LHH image set (AUC 0.75 ± 0.051 and 0.65- Supplemental Tables 8 and 9 show KRAS mutation status prediction results based on feature selection methods and image sets. In these results, feature selection performance ranges from 0.5 to 0.83, and the combination of SM feature selection with PET_LOG_4.5S image set had the highest performance (AUC 0.66 ± 0.093 and 0.51-0.79), followed by VT_SM feature selection with CT_LOG_3.5S image set (AUC 0.66 ± 0.079 and 0.55-0.8), SM feature selection with Figure 6 a shows the box plot of KRAS mutation status prediction based on feature selection methods.
KRAS mutation status prediction results based on classifier and image sets is presented in supplemental Tables 10 and 11 (mean ± SD and Min-Max). Here, the classifier performance ranges from 0.5 to 0.83 and the combination of SVM classifier with CT_LOG_3.5S image set had the highest performance (AUC 0.79 ± 0.021 and 0.76-0.8), followed by BNB classifier PET_W_HHH image set (AUC 0.75 ± 0.1 and 0.6-0.81) and SGD classifier with CTD_LOG_4 S image set (AUC: 0.71 ± 0.08 and 0.56-0.81). Figure 6 b indicates the box plot of KRAS mutation status prediction based on feature selection methods. Furthermore, supplemental Table 12 compares (q-value, t test) on predictive performance (AUC) of univariate vs. multivariate analysis approaches for EGFR and KRAS mutation status for different image sets. The data show that multivariate analysis significantly improved prediction power against univariate analysis, underscoring the importance of utilizing machine learning methods for improved performance.
Discussion
Accurate detection of EGFR/KRAS mutation status in NSCLCs allows improved selection of patients for effective therapeutic strategies [3] . Although bio-techniques provide intra-and inter-tumor EGFR/KRAS mutation status in Shiri I. et al.: Imaging-Genomics Analysis for EGFR and KRAS Prediction patients, they are not entirely feasible and suffer from limitations [40] . In the present study, we developed a comprehensive radiomics framework that calculates radiomic features from low-dose CT, diagnostic CT, and PET images to predict EGFR and KRAS mutation status using univariate and multivariate ML algorithms in NSCLCs patients. In our radiogenomics study, several radiomics models were found predictive for EGFR and KRAS mutation status, and as such are suitable for non-invasive cost-effective assessment.
In recent years, the field of radiogenomics-correlation of imaging features with genomic parameters-has garnered significant interest, as a non-invasive assessment framework to tailor therapy based on imaging biomarkers and underlying biological pathways [8, 41, 42] . In our work, we observed a wide range of predictive model performances for different radiomics features, feature selection, and classification algorithms and for different imaging modalities. For EGFR and KRAS mutation status prediction, univariate analysis of radiomic features and crosscombination of imaging/validation /feature selection/ classification as multivariate analysis methods resulted in a wide range of performance (AUC 0.5~0.83). The best predictive power of conventional PET parameters was achieved by SUV peak (AUC: 0.69, p value = 0.0002) and MTV (AUC 0.55, p value = 0.0011) for EGFR and KRAS. Univariate analysis of extracted radiomic features improved prediction power up to AUC 0.75 (q-value 0.003, Short-Run Emphasis feature of GLRLM from LOG preprocessed PET images with a sigma value of 1.5) and AUC 0.71 (q-value 0.00005, the Large Dependence Low Gray-Level Emphasis from GLDM in LOG preprocessed CTD images with a sigma value of 5) for EGFR and KRAS, respectively. Furthermore, the machine learning algorithm improved the prediction power of gene mutation status up to AUC 0.82 for EGFR (LOG preprocessed PET image set with a sigma of 3 with VT feature selector and SGD classifier) and AUC 0.83 for KRAS (CT image set with a sigma of 3.5 with SM feature selector and SGD classifier). Using radiomics feature and machine learning algorithm outperformed conventional methods in prediction of EGFR and KRAS gene mutation status in NSCLC patients.
The role of feature selection is more prominent in crosscombination of feature selection and image sets for EGFR mutation status prediction. Random forest (RF) and support vector machine (SVM) methods proved to yield a higher performance in EGFR and KRAS prediction. For classification, the selection of an appropriate algorithm has a more prominent role. Zhao et al. [19] developed a conventional radiomics model and 3D deep learning system to predict EGFR-mutant pulmonary adenocarcinoma from CT images, the best-reported AUC was 75.8 using deep learning. However, in the present study, the EGFR status achieved an AUC 0.82 which shows the role of combining different image sets, feature selector, and classifier. Parmer et al. [24] compared 14 feature selection and 12 classification methods in terms of performance and stability and found that the Wilcoxon rank-sum test and random forest (RF) had the highest prognostic performance for feature selection and classification, respectively, while demonstrating high stability against data perturbation. Moreover, Zhang et al. [43] built a 54-cross-combination ML algorithm framework including six feature selections and nine classification methods for survival prediction of advanced nasopharyngeal carcinoma. They found that using RF for both feature selection and classification had the highest prognostic performance, followed by RF + AB and sure independence screening (SIS) + linear support vector machines (SVMs). Abdollahi et al. [44] studied different combinations of feature selector and classifier for predition of intensitymodulated radiation therapy response, Gleason score, and stage in prostate cancer and showed that different tasks of classification can be achived by different combinations of feature selector and classifiers. In addition, we compared the predictive power of conventional PET parameters and radiomic features. In our radiogenomics study, we showed that radiomics features and machine learning-based radiomic models are more predictive than conventional parameters. Du et al. [45] provided a cross-combination of six features selection and seven classifiers for PET/CT radiomics-based differentiation between recurrence and inflammation in nasopharyngeal carcinoma. They reported the most accurate and reliable machine learning methods through the different combinations of feature selectors and classifier methods. They suggested that parameter tuning can result in higher performance; however, at the same time, it may cause overfitting. In our current study, we have fine-tuned the model hyperparameters and tested them on external validation set to prevent overfitting. Wang et al. [19] and Zhao et al. [20] recently performed a radiomics study using deep learning for EGFR prediction using CT images. In the radiomic study reported by Wang et al. [19] , radiomic features extraction was performed using PyRadiomics with eight features selected using recursive feature elimination imported into a random forest classifier. They reported AUCs of 0.64 and 0.81 on external validation sets for radiomics and deep learning models. In Zhao et al. [20] study, 401 features were selected using an Intra Class Correlation (ICC) test that were subsequently input to logistic regression to construct the radiomics model. They reported AUCs of 0.68 and 0.75 for radiomics and deep learning models. Tu et al. [46] more recently developed a radiomics model based on CT image features and selected the features based on an ICC test and then predicted EGFR mutation using logistic regression models. They reported an AUC of 0.76 for their radiomics signature and an AUC of 0.798 for their integrated model (radiomic + clinical). In comparison with their imaging modality and machine learning algorithms, our current study resulted in 0.75 and 0.78 as the highest AUCs using low-dose CT and CTD images, SM and SKB as features selector, and DT and SGD classifiers, respectively. The random forest and logistics Shiri I. et al.: Imaging-Genomics Analysis for EGFR and KRAS Prediction regression classifier resulted in 0.71 and 0.75 AUCs in our study using CT images. An AUC of 0.82 was achieved via LOG preprocessed PET images, the VT feature selector, and the SGD classifier. Owing to the lack of one-fits-all models in machine learning, different combinations of imaging modalities, feature selectors, and classifiers can provide different results. In the current study, we considered a wide variety of imaging modalities, feature selectors, and classifiers to provide a high-performance model for EGFR and KRAS mutation prediction.
Rizzo et al. [47] developed a radiogenomic model based on CT radiological hand-crafted features to predict EGFR and KRAS mutations in NSCLC patients. In their study, 20 radiological features were extracted by two radiologists, with the analysis performed on an external validation set. They reported AUCs of 0.82 and 0.60 for prediction of EGFR and KRAS, respectively. A recent study performed by Li et al. [21] reported EGFR mutation status using conventional PET/CT SUV and radiomic features. For conventional PET SUV features, they reported AUCs of 0.621 (p value = 0.026), 0.624 (p value = 0.023), 0.615 (p value = 0.035), and 0.597 (p value = 0.074) for SUV max , SUV mean , SUV peak , and TLG, respectively. In their radiomics analysis using the LASSO feature selector and an ensemble classifier, they reported AUCs of 0.667, 0.789, and 0.805 for CT, PET, and PET/CT images radiomic model and 0.686, 0.774, and 0.822 for CT, PET, and PET/CT radiomics + clinical model, respectively. In our current study for EGFR prediction, the conventional SUV PET features provided AUCs of 0.69 (p value = 0.0002), 0.60 (p value = 0.0003), 0.59 (p valueG 0.0001), 0.55 (p value G 0.0001), and 0.56 (p value = 0.0004) for SUV peak , SUL peak , SUV max , SUL max , and MTV, respectively. For ensemble learning in our current study, the combination of VT feature selector with AB classifier in LOG preprocessed CTD images results in an AUC of 0.73. Combination of SM feature selector with AB classifier in LLL wavelet preprocessed low-dose CT image results in an AUC of 0.73, while the combination of VT feature selector with RF classifier in LHH wavelet preprocessed PET images resulted in AUC of 0.79. The best radiomics model for the prediction of EGFR and KRAS was achieved via the PET LOG preprocessing method, the VT features selector, the SGD classifier (PET_LOG_3.5S + VT + SGD, AUC 0.82), and the LOG preprocessing of CT images, the SM feature selector, and the SGD model (CT_LOG_3.5S + SM + SGD, AUC 0.83), respectively.
Pinheiro et al. [22] reported on a radiomics study on the same public datasets used in our current study for EGFR and KRAS prediction using only CT image features (radiomics and semantic radiological features) on a 80 %/20 % training and test setup (116 patients for EGFR and 114 for KRAS). They extracted wavelet and LOG preprocessed features using PyRadiomics from 3D segmented CT images, and subsequently used principal component analysis (PCA) followed by t-Distributed Stochastic Neighbor Embedding (t-SNE) to reduce the extracted features. Subsequently, an Extreme Gradient Boosting (XGBoost) classifier was used to classify KRAS and EGFR gene mutation status. They reported AUCs of 0.57 ± 0.12 and 0.50 ± 0.01 using radiomics model and 0.74 ± 0.08 and 0.50 ± 0.07 for semantic features for EGFR and KRAS prediction, respectively. In our current study, the CT radiomics feature model arrived at AUCs of 0.78 and 0.83 by SGD_SM and SGD_SM models for EGFR and KRAS prediction in 68 external validation sets, respectively.
Radiomics/genomics studies suffer from several challenges, and a robust framework for clinical decision making is highly desired [41, 48, 49] . As an approved guideline, standardization efforts (IBSI in particular) [38] have sought to address the challenge of reproducing and validating reported findings by comparing and standardizing definitions and implementation of several image feature sets between participating institutions. The IBSI also provides image biomarker nomenclature and definitions, benchmark datasets, and benchmark values to verify image processing and image biomarker calculations, as well as reporting guidelines, for high-throughput image analysis [38] . In this study, we followed the IBSI protocol to resample all images to a constant voxel size to reduce feature sensitivity to variable image generation parameters [38] , also ensuring the robustness and reproducibility of the study using publicly available datasets and open-source feature extraction and machine learning library [50] . Having an image dataset generated using varying acquisition [51, 52] , reconstruction [53] , processing, and segmentation [54] results produce inconsistencies in feature evaluation. Future studies are required to assess the effect of other sources of variation in scans, including but not limited to post-injection scan time window, administered dosage, reconstruction parameters (different inherent spatial resolution, PSF kernel, iterations, subsets, time-offlight (TOF) setting, etc.). Combining the radiomic features and clinical information would also be suggested to investigate the possibility of predicted model improvement. The significance of our study is in addressing convolutional biomarkers vs. radiomics analysis with various ML algorithms on three different imaging modalities.
The limited size of a dataset is a limiting factor in radiomic studies, as the analysis with many radiomic features and only a few imaging data is prone to overfitting. We tuned our models using 10-fold cross-validation to reduce the sensitivity of our results to input data and repeated for 20 times to make our results more reliable, and all model evaluations were performed on 68 patient's independent validation set which was not used in the training process. Our presented results were developed using a standardized radiomics analysis workflow that showed strong and significant predictability of gene mutations. Specifically, in the feature selection phase, we used ML algorithms to reduce the number of features to decrease the dimensionality and reduce overfitting.
Conclusion
We demonstrated that prediction of EGFR and KRAS mutation status in NSCLC patients can be significantly improved via robust and systematic radiomics analysis. We evaluated different machine learning methods to find optimal methods for radiogenomics analyses. Overall, we showed that radiomic features extracted from different imaging modalities can be used for effective prediction of EGFR and KRAS mutation status, having significantly higher predictive power relative to conventional imaging biomarkers.
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